로그인 후에 확인 가능합니다.

전문진료분야

임상대상환자보유

100이상 ~ 500미만

SCI논문명

1. Kim CY (1저자), Paek SH, Nam DH, Chang JH, Hong YK, Kim JH, Kim OL, Kim SH. Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial. J Neurooncol. 2020 Feb;146(3):399-406. doi: 10.1007/s11060-019-03361-2. Epub 2020 Feb 4. PubMed PMID: 32020470.

2. Ha SW, Hwang K, Jin J, Cho AS, Kim TY, Hwang SI, Lee HJ, Kim CY(교신저자). Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system. Int J Nanomedicine. 2019;14:3743-3752. doi: 10.2147/IJN.S193258. eCollection 2019. PubMed PMID: 31213800; PubMed Central PMCID: PMC6539164.

3. Hwang K, Koh EJ, Choi EJ, Kang TH, Han JH, Choe G, Park SH, Yearley JH, Annamalai L, Blumenschein W, Sathe M, McClanahan T, Jung H, Wang KC, Kim SK, Kim CY(교신저자). PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population. J Neurooncol. 2018 Sep;139(2):281-291. doi: 10.1007/s11060-018-2886-5. Epub 2018 May 5. PubMed PMID: 29730815.

보유특허명

0

소속학회

의료분야 관심 키워드